Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Change in Account Payables (2021 - 2025)

PAVmed has reported Change in Account Payables over the past 5 years, most recently at $339000.0 for Q4 2025.

  • Quarterly results put Change in Account Payables at $339000.0 for Q4 2025, up 78.42% from a year ago — trailing twelve months through Dec 2025 was $24000.0 (up 103.23% YoY), and the annual figure for FY2025 was $24000.0, up 140.68%.
  • Change in Account Payables for Q4 2025 was $339000.0 at PAVmed, up from -$47000.0 in the prior quarter.
  • Over the last five years, Change in Account Payables for PAVM hit a ceiling of $3.9 million in Q1 2022 and a floor of -$2.9 million in Q2 2022.
  • Median Change in Account Payables over the past 5 years was -$97000.0 (2023), compared with a mean of -$96052.6.
  • Peak annual rise in Change in Account Payables hit 466.54% in 2022, while the deepest fall reached 266.57% in 2022.
  • PAVmed's Change in Account Payables stood at -$2.7 million in 2021, then soared by 108.73% to $239000.0 in 2022, then plummeted by 259.0% to -$380000.0 in 2023, then surged by 150.0% to $190000.0 in 2024, then skyrocketed by 78.42% to $339000.0 in 2025.
  • The last three reported values for Change in Account Payables were $339000.0 (Q4 2025), -$47000.0 (Q3 2025), and $18000.0 (Q2 2025) per Business Quant data.